Boston Scientific discontinues angiographic catheters
Boston Scientific removes angiographic and imaging catheters from the market following high-severity device recalls and safety alerts.
4 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 4 separate news trends connected to Investor Impact, spanning June 21, 2026 through September 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 27 article observations and 25 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Boston Scientific removes angiographic and imaging catheters from the market following high-severity device recalls and safety alerts.
A $245 million patent dispute verdict has investors watching Guardant Health's next moves.
Walmart's upcoming earnings report is expected to significantly impact retail investors and the broader market.
Fox's acquisition of Roku reshapes the streaming landscape, sparking investor interest and consumer concern.